Honey - A novel antidiabetic agent

International Journal of Biological Sciences

Volumn 8, Issue 6, 2012, Pages 913-934

  Erejuwa, Omotayo O ^a   Sulaiman, Siti A ^a   Ab Wahab, Mohd S ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Antidiabetic; Diabetes mellitus; Glycemic control; Honey; Hypoglycemic; Insu lin; Liver; Pancreas

Indexed keywords

ANTIDIABETIC AGENT;

ANIMAL; DIABETES MELLITUS; GLUCOSE INTOLERANCE; HONEY; HUMAN; REVIEW;

ANIMALS; DIABETES MELLITUS; GLUCOSE INTOLERANCE; HONEY; HUMANS; HYPOGLYCEMIC AGENTS;

APOIDEA;

EID: 84864378426     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.3697     Document Type: Review

References (230)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87: 4-14.
2. Kokil GR, Rewatkar PV, Verma A, et al. Pharmacology and chemistry of diabetes mellitus and antidiabetic drugs: a critical review. Curr Med Chem. 2010; 17: 4405-23.
3. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract. 2010; 87: 15-9.
4. [Internet] Bogdanov S. Honey as nutrient and functional food. http://www.bee-hexagon.net
5. Wang J, Li QX. Chemical composition, characterization, and differentiation of honey botanical and geographical origins. Adv Food Nutr Res. 2011; 62: 89-137.
6. Molan P. The limitations of the methods of identifying the floral source of honeys. Bee World. 1998; 97: 59-68.
7. Ramírez-Arriaga E, Navarro-Calvo AL, Díaz-Carbajal E. Botanical characterisation of Mexican honeys from a subtropical region (Oaxaca) based on pollen analysis. Grana. 2011; 50: 40-5.
8. Gheldof N, Wang XH, Engeseth NJ. Identification and quantification of antioxidant components of honeys from various floral sources. J Agric Food Chem. 2002; 50: 5870-7.
9. Bogdanov S, Jurendic T, Sieber R, et al. Honey for nutrition and health: a review. J Am Coll Nutr. 2008; 27: 677-89.
10. Beretta G, Gelmini F, Lodi V, et al. Profile of nitric oxide (NO) metabolites (nitrate, nitrite and N-nitroso groups) in honeys of different botanical origin: nitrate accumulation as index of origin, quality and of therapeutic opportunities. J Pharm Biomed Anal. 2010; 53: 343-9.
11. Beretta G, Caneva E, Facino RM. Kynurenic acid in honey from arboreal plants: MS and NMR evidence. Planta Med. 2007; 73: 1592-5.
12. Crane E. History of honey. In: Crane E, ed. Honey, a comprehensive survey. London: William Heinemann; 1975: 439-88.
13. Heitkamp K, Busch-Stockfisch M. [The pros and cons of honey--are statements about the effects of honey "scientifically verified"?]. Z Lebensm Unters Forsch. 1986; 182: 279-86.
14. Rakha MK, Nabil ZI, Hussein AA. Cardioactive and vasoactive effects of natural wild honey against cardiac malperformance induced by hyperadrenergic activity. J Med Food. 2008; 11: 91-8.
15. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Hepatoprotective effect of tualang honey supplementation in streptozotocin-induced diabetic rats. Int J Appl Res Nat Prod. 2012; 4: 37-41.
16. Erejuwa OO, Gurtu S, Sulaiman SA, et al. Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res. 2010; 80: 74-82.
17. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocin-induced diabetic rats. Int J Mol Sci. 2010; 11: 2056-66.
18. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in the kidneys of streptozotocin-induced diabetic rats. Int J Mol Sci. 2011; 12: 829-43.
19. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Antioxidant protection of Malaysian tualang honey in pancreas of normal and streptozotocin-induced diabetic rats. Ann Endocrinol (Paris). 2010; 71: 291-6.
20. Beretta G, Orioli M, Facino RM. Antioxidant and radical scavenging activity of honey in endothelial cell cultures (EA. hy926). Planta Med. 2007; 73: 1182-9.
21. Beretta G, Granata P, Ferrero M, et al. Standardization of antioxidant properties of honey by a combination of spectrophotometric/fluorimetric assays and chemometrics. Anal Chim Acta. 2005; 533: 185-91.
22. Al-Waili N. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate. Eur J Med Res. 2003; 8: 295-303.
23. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Honey supplementation in spontaneously hypertensive rats elicits antihypertensive effect via amelioration of renal oxidative stress. Oxid Med Cell Longev. 2012; 2012: 1-14.
24. Tan HT, Rahman RA, Gan SH, et al. The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey. BMC Complement Altern Med. 2009; 9: 1-8.
25. Feas X, Estevinho ML. A survey of the in vitro antifungal activity of heather (erica sp.) organic honey. J Med Food. 2011; 14: 1284-8.
26. Zeina B, Othman O, Al-Assad S. Effect of honey versus thyme on Rubella virus survival in vitro. J Altern Complement Med. 1996; 2: 345-8.
27. Kassim M, Achoui M, Mustafa MR, et al. Ellagic acid, phenolic acids, and flavonoids in Malaysian honey extracts demonstrate in vitro anti-inflammatory activity. Nutr Res. 2010; 30: 650-9.
28. Fukuda M, Kobayashi K, Hirono Y, et al. Jungle honey enhances immune function and antitumor activity. Evid Based Complement Alternat Med. 2011; 2011: 1-8.
29. [Internet] The chemistry of carbohydrates found in food. http://www.medbio.info
30. [Internet] Carbohydrates. http://www.reboundhealth.com/cms/topic-carbohydrates.html
31. Wright EM, Hirayama BA, Loo DF. Active sugar transport in health and disease. J Intern Med. 2007; 261: 32-43.
32. Vaisman N, Niv E, Izkhakov Y. Catalytic amounts of fructose may improve glucose tolerance in subjects with uncontrolled non-insulin-dependent diabetes. Clin Nutr. 2006; 25: 617-21.
33. Stanhope KL, Griffen SC, Bremer AA, et al. Metabolic responses to prolonged consumption of glucose-and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Am J Clin Nutr. 2011; 94: 112-9.
34. Kwon S, Kim YJ, Kim MK. Effect of fructose or sucrose feeding with different levels on oral glucose tolerance test in normal and type 2 diabetic rats. Nutr Res Pract. 2008; 2: 252-8.
35. Erejuwa OO, Sulaiman SA, Wahab MS. Fructose might contribute to the hypoglycemic effect of honey. Molecules. 2012; 17: 1900-15.
36. Moran TH, McHugh PR. Distinctions among three sugars in their effects on gastric emptying and satiety. Am J Physiol. 1981; 241: R25-30.
37. Kellett GL, Brot-Laroche E, Mace OJ, et al. Sugar absorption in the intestine: the role of GLUT2. Annu Rev Nutr. 2008; 28: 35-54.
38. Kashimura J, Nagai Y. Inhibitory effect of palatinose on glucose absorption in everted rat gut. J Nutr Sci Vitaminol (Tokyo). 2007; 53: 87-9.
39. Lina BA, Jonker D, Kozianowski G. Isomaltulose (Palatinose): a review of biological and toxicological studies. Food Chem Toxicol. 2002; 40: 1375-81.
40. Thibault L. Dietary carbohydrates: effects on self-selection, plasma glucose and insulin, and brain indoleaminergic systems in rat. Appetite. 1994; 23: 275-86.
41. Gregory PC, McFadyen M, Rayner DV. Relation between gastric emptying and short-term regulation of food intake in the pig. Physiol Behav. 1989; 45: 677-83.
42. Henry RR, Crapo PA, Thorburn AW. Current issues in fructose metabolism. Annu Rev Nutr. 1991; 11: 21-39.
43. Meirelles CJ, Oliveira LA, Jordao AA, et al. Metabolic effects of the ingestion of different fructose sources in rats. Exp Clin Endocrinol Diabetes. 2011; 119: 218-20.
44. Lavin JH, Wittert GA, Andrews J, et al. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate. Am J Clin Nutr. 1998; 68: 591-8.
45. Anderson GH, Woodend D. Effect of glycemic carbohydrates on short-term satiety and food intake. Nutr Rev. 2003; 61: S17-26.
46. Madero M, Arriaga JC, Jalal D, et al. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial. Metabolism. 2011; 60: 1551-9.
47. Bocarsly ME, Powell ES, Avena NM, et al. High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels. Pharmacol Biochem Behav. 2010; 97: 101-6.
48. Jones HF, Butler RN, Brooks DA. Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol. 2011; 300: G202-6.
49. Gouyon F, Caillaud L, Carriere V, et al. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol. 2003; 552: 823-32.
50. Miyamoto K, Hase K, Takagi T, et al. Differential responses of intestinal glucose transporter mRNA transcripts to levels of dietary sugars. Biochem J. 1993; 295: 211-5.
51. Riby JE, Fujisawa T, Kretchmer N. Fructose absorption. Am J Clin Nutr. 1993; 58: 748S-53S.
52. Ushijima K, Riby JE, Fujisawa T, et al. Absorption of fructose by isolated small intestine of rats is via a specific saturable carrier in the absence of glucose and by the disaccharidase-related transport system in the presence of glucose. J Nutr. 1995; 125: 2156-64.
53. Fujisawa T, Riby J, Kretchmer N. Intestinal absorption of fructose in the rat. Gastroenterology. 1991; 101: 360-7.
54. Fine KD, Santa Ana CA, Porter JL, et al. Mechanism by which glucose stimulates the passive absorption of small solutes by the human jejunum in vivo. Gastroenterology. 1994; 107: 389-95.
55. Ariefdjohan MW, Martin BR, Lachcik PJ, et al. Acute and chronic effects of honey and its carbohydrate constituents on calcium absorption in rats. J Agric Food Chem. 2008; 56: 2649-54.
56. Bhor VM, Sivakami S. Regional variations in intestinal brush border membrane fluidity and function during diabetes and the role of oxidative stress and non-enzymatic glycation. Mol Cell Biochem. 2003; 252: 125-32.
57. Zoubi SA, Williams MD, Mayhew TM, et al. Number and ultrastructure of epithelial cells in crypts and villi along the streptozotocin-diabetic small intestine: a quantitative study on the effects of insulin and aldose reductase inhibition. Virchows Arch. 1995; 427: 187-93.
58. Fedorak RN, Gershon MD, Field M. Induction of intestinal glucose carriers in streptozocin-treated chronically diabetic rats. Gastroenterology. 1989; 96: 37-44.
59. Sharma SD, Sivakami S. Responses of intestinal and renal alpha-glycosidases to alloxan and streptozotocin-induced diabetes: a comparative study. Biochem Mol Biol Int. 1998; 44: 647-56.
60. Shirpoor A, Ansari MH, Salami S, et al. Effect of vitamin E on oxidative stress status in small intestine of diabetic rat. World J Gastroenterol. 2007; 13: 4340-4.
61. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Effects of Malaysian tualang honey supplementation on glycemia, free radical scavenging enzymes and markers of oxidative stress in kidneys of normal and streptozotocin-induced diabetic rats. Int J Cardiol. 2009; 137: S45.
62. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Effect of glibenclamide alone versus glibenclamide and honey on oxidative stress in pancreas of streptozotocin-induced diabetic rats. Int J Appl Res Nat Prod. 2011; 4: 1-10.
63. Eraslan G, Kanbur M, Silici S, et al. Beneficial effect of pine honey on trichlorfon induced some biochemical alterations in mice. Ecotoxicol Environ Saf. 2010; 73: 1084-91.
64. Faria A, Mateus N, de Freitas V, et al. Modulation of MPP+ uptake by procyanidins in Caco-2 cells: involvement of oxidation/reduction reactions. FEBS Lett. 2006; 580: 155-60.
65. Faria A, Monteiro R, Pestana D, et al. Intestinal oxidative state can alter nutrient and drug bioavailability. Oxid Med Cell Longev. 2009; 2: 322-7.
66. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats. Int J Biol Sci. 2011; 7: 244-52.
67. Naito Y, Takagi T, Oya-Ito T, et al. Impaired gastric ulcer healing in diabetic mice: role of methylglyoxal. J Physiol Pharmacol. 2009; 60 Suppl 7: 123-30.
68. Boehme MW, Autschbach F, Ell C, et al. Prevalence of silent gastric ulcer, erosions or severe acute gastritis in patients with type 2 diabetes mellitus-a cross-sectional study. Hepatogastroenterology. 2007; 54: 643-8.
69. Thomsen RW, Riis A, Christensen S, et al. Diabetes and 30-day mortality from peptic ulcer bleeding and perforation: a Danish population-based cohort study. Diabetes Care. 2006; 29: 805-10.
70. Gharzouli K, Amira S, Gharzouli A, et al. Gastroprotective effects of honey and glucose-fructose-sucrose-maltose mixture against ethanol-, indomethacin-, and acidified aspirin-induced lesions in the rat. Exp Toxicol Pathol. 2002; 54: 217-21.
71. Osato MS, Reddy SG, Graham DY. Osmotic effect of honey on growth and viability of Helicobacter pylori. Dig Dis Sci. 1999; 44: 462-4.
72. Gollu A, Kismet K, Kilicoglu B, et al. Effect of honey on intestinal morphology, intraabdominal adhesions and anastomotic healing. Phytother Res. 2008; 22: 1243-7.
73. Gencay C, Kilicoglu SS, Kismet K, et al. Effect of honey on bacterial translocation and intestinal morphology in obstructive jaundice. World J Gastroenterol. 2008; 14: 3410-5.
74. Ergul E, Ergul S. The effect of honey on the intestinal anastomotic wound healing in rats with obstructive jaundice. Bratisl Lek Listy. 2010; 111: 265-70.
75. Quigley EM. Prebiotics and probiotics; modifying and mining the microbiota. Pharmacol Res. 2010; 61: 213-8.
76. Bjorkholm B, Bok CM, Lundin A, et al. Intestinal microbiota regulate xenobiotic metabolism in the liver. PLoS One. 2009; 4 (e6958): 1-8.
77. Heijtz RD, Wang S, Anuar F, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011; 108: 3047-52.
78. Cani PD, Delzenne NM, Amar J, et al. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris). 2008; 56: 305-9.
79. Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007; 50: 2374-83.
80. Erejuwa OO, Sulaiman SA, Wahab MS. Oligosaccharides might contribute to the antidiabetic effect of honey: a review of the literature. Molecules. 2012; 17: 248-66.
81. Sanz ML, Gonzalez M, Lorenzo C, et al. Carbohydrate composition and physicochemical properties of artisanal honeys from Madrid (Spain): occurrence of Echium sp. honey. J Sci Food Agric. 2004; 84: 1577-84.
82. Munstedt K, Sheybani B, Hauenschild A, et al. Effects of basswood honey, honey-comparable glucose-fructose solution, and oral glucose tolerance test solution on serum insulin, glucose, and C-peptide concentrations in healthy subjects. J Med Food. 2008; 11: 424-8.
83. Munstedt K, Bohme M, Hauenschild A, et al. Consumption of rapeseed honey leads to higher serum fructose levels compared with analogue glucose/fructose solutions. Eur J Clin Nutr. 2011; 65: 77-80.
84. [Internet] Gentiobiose. http://www.biosite.dk
85. [Internet] Raffinose, palatinose and turanose. http://www.chemblink.com
86. [Internet] Isomaltose, cellobiose, melezitose, trehalose and maltotriose. http://www.extrasynthese.com
87. [Internet] Maltulose, panose and erlose. http://www.carbosynth.com
88. Shamala TR, Shri Jyothi Y, Saibaba P. Stimulatory effect of honey on multiplication of lactic acid bacteria under in vitro and in vivo conditions. Lett Appl Microbiol. 2000; 30: 453-5.
89. Chick H, Shin HS, Ustunol Z. Growth and acid production by lactic acid bacteria and bifidobacteria grown in skim milk containing honey. J Food Sci. 2001; 66: 478-81.
90. Kajiwara S, Gandhi H, Ustunol Z. Effect of honey on the growth of and acid production by human intestinal Bifidobacterium spp.: an in vitro comparison with commercial oligosaccharides and inulin. J Food Prot. 2002; 65: 214-8.
91. Sanz ML, Polemis N, Morales V, et al. In vitro investigation into the potential prebiotic activity of honey oligosaccharides. J Agric Food Chem. 2005; 53: 2914-21.
92. Shin HS, Ustunol Z. Carbohydrate composition of honey from different floral sources and their influence on growth of selected intestinal bacteria: An in vitro comparison. Food Res Int. 2005; 38: 721-8.
93. Riazi A, Zia H. Growth and viability of yogurt starter organisms inhoney-sweetened skimmed mil. Afr J Biotech. 2008; 7: 2055-63.
94. Ezz El-Arab AM, Girgis SM, Hegazy EM, et al. Effect of dietary honey on intestinal microflora and toxicity of mycotoxins in mice. BMC Complement Altern Med. 2006; 6: 1-13.
95. Popa D, Ustunol Z. Influence of sucrose, high fructose corn syrup and honey from different floral sources on growth and acidproduction by lactic acid bacteria and bifidobacteria. Int J Dairy Technol. 2011; 46: 247-53.
96. Kawai K, Okuda Y, Yamashita K. Changes in blood glucose and insulin after an oral palatinose administration in normal subjects. Endocrinol Jpn. 1985; 32: 933-6.
97. Tonouchi H, Yamaji T, Uchida M, et al. Studies on absorption and metabolism of palatinose (isomaltulose) in rats. Br J Nutr. 2011; 105: 10
98. Gentilcore D, Vanis L, Teng JC, et al. The oligosaccharide alpha-cyclodextrin has modest effects to slow gastric emptying and modify the glycaemic response to sucrose in healthy older adults. Br J Nutr. 2011; 106: 583-7.
99. Klip A, Vranic M. Muscle, liver, and pancreas: Three Musketeers fighting to control glycemia. Am J Physiol Endocrinol Metab. 2006; 291: E1141-3.
100. Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr. 1993; 58: 754S-65S.
101. Van Schaftingen E, Davies DR. Fructose administration stimulates glucose phosphorylation in the livers of anesthetized rats. FASEB J. 1991; 5: 326-30.
102. Youn JH, Kaslow HR, Bergman RN. Fructose effect to suppress hepatic glycogen degradation. J Biol Chem. 1987; 262: 11470-7.
103. Ciudad CJ, Carabaza A, Guinovart JJ. Glycogen synthesis from glucose and fructose in hepatocytes from diabetic rats. Arch Biochem Biophys. 1988; 267: 437-47.
104. Regan JJ, Jr., Doorneweerd DD, Gilboe DP, et al. Influence of fructose on the glycogen synthase and phosphorylase systems in rat liver. Metabolism. 1980; 29: 965-9.
105. Shiota M, Galassetti P, Igawa K, et al. Inclusion of low amounts of fructose with an intraportal glucose load increases net hepatic glucose uptake in the presence of relative insulin deficiency in dog. Am J Physiol Endocrinol Metab. 2005; 288: E1160-7.
106. Wei Y, Bizeau ME, Pagliassotti MJ. An acute increase in fructose concentration increases hepatic glucose-6-phosphatase mRNA via mechanisms that are independent of glycogen synthase kinase-3 in rats. J Nutr. 2004; 134: 545-51.
107. Cherrington AD. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes. 1999; 48: 1198-214.
108. Wright EM, Martin MG, Turk E. Intestinal absorption in health and disease--sugars. Best Pract Res Clin Gastroenterol. 2003; 17: 943-56.
109. Leeds JS, Forman EM, Morley S, et al. Abnormal liver function tests in patients with type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. Diabet Med. 2009; 26: 1235-41.
110. Al-Waili NS. Intravenous and intrapulmonary administration of honey solution to healthy sheep: effects on blood sugar, renal and liver function tests, bone marrow function, lipid profile, and carbon tetrachloride-induced liver injury. J Med Food. 2003; 6: 231-47.
111. Dias AS, Porawski M, Alonso M, et al. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr. 2005; 135: 2299-304.
112. Kilicoglu B, Gencay C, Kismet K, et al. The ultrastructural research of liver in experimental obstructive jaundice and effect of honey. Am J Surg. 2008; 195: 249-56.
113. Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr. 2006; 84: 274-88.
114. Huynh M, Luiken JJ, Coumans W, et al. Dietary fructose during the suckling period increases body weight and fatty acid uptake into skeletal muscle in adult rats. Obesity (Silver Spring). 2008; 16: 1755-62.
115. Bocarsly ME, Powell ES, Avena NM, et al. High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels. Pharmacol Biochem Behav. 2010; 97: 101-6.
116. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009; 119: 1322-34.
117. Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010; 90: 23-46.
118. Razquin C, Martinez JA, Martinez-Gonzalez MA, et al. 3 years follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity and reduced body weight gain. Eur J Clin Nutr. 2009; 63: 1387-93.
119. Nemoseck TM, Carmody EG, Furchner-Evanson A, et al. Honey promotes lower weight gain, adiposity, and triglycerides than sucrose in rats. Nutr Res. 2011; 31: 55-60.
120. Bahrami M, Ataie-Jafari A, Hosseini S, Foruzanfar MH, Rahmani M, Pajouhi M. Effects of natural honey consumption in diabetic patients: an 8-week randomized clinical trial. Int J Food Sci Nutr. 2009; 60: 618-26.
121. Yaghoobi N, Al-Waili N, Ghayour-Mobarhan M, et al. Natural honey and cardiovascular risk factors; effects on blood glucose, cholesterol, triacylglycerole, CRP, and body weight compared with sucrose. ScientificWorldJournal. 2008; 8: 463-9.
122. Dolan LC, Potter SM, Burdock GA. Evidence-based review on the effect of normal dietary consumption of fructose on blood lipids and body weight of overweight and obese individuals. Crit Rev Food Sci Nutr. 2010; 50: 889-918.
123. Perez-Pozo SE, Schold J, Nakagawa T, et al. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond). 2009; 34: 454-61.
124. Rohlfing CL, Wiedmeyer HM, Little RR, et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002; 25: 275-8.
125. Akhtar MS, Khan MS. Glycaemic responses to three different honeys given to normal and alloxan-diabetic rabbits. J Pak Med Assoc. 1989; 39: 107-13.
126. Fasanmade AA, Alabi OT. Differential effect of honey on selected variables in alloxan-induced and fructose-induced diabetic rats. Afr J Biomed Res. 2008; 11: 191-6.
127. Chepulis L, Starkey N. The long-term effects of feeding honey compared with sucrose and a sugar-free diet on weight gain, lipid profiles, and DEXA measurements in rats. J Food Sci. 2008; 73: H1-7.
128. Shambaugh P, Worthington V, Herbert JH. Differential effects of honey, sucrose, and fructose on blood sugar levels. J Manipulative Physiol Ther. 1990; 13: 322-5.
129. Ahmad A, Azim MK, Mesaik MA, et al. Natural honey modulates physiological glycemic response compared to simulated honey and D-glucose. J Food Sci. 2008; 73: H165-7.
130. Abdulrhman M, El-Hefnawy M, Hussein R, et al. The glycemic and peak incremental indices of honey, sucrose and glucose in patients with type 1 diabetes mellitus: effects on C-peptide level-a pilot study. Acta Diabetol. 2011; 48: 89-94.
131. Samanta A, Burden AC, Jones GR. Plasma glucose responses to glucose, sucrose, and honey in patients with diabetes mellitus: an analysis of glycaemic and peak incremental indices. Diabet Med. 1985; 2: 371-3.
132. Abdulrhman M, El-Hefnawy M, Ali R, et al. Honey and type 1 diabetes mellitus. In: Liu CP, ed. Type 1 diabetes-complications, pathogenesis, and alternative treatments. Croatia: InTech; 2011: 228-33.
133. Agrawal OP, Pachauri A, Yadav H, et al. Subjects with impaired glucose tolerance exhibit a high degree of tolerance to honey. J Med Food. 2007; 10: 473-8.
134. Erejuwa OO. The use of honey in diabetes mellitus: is it beneficial or detrimental? Int J Endocrinol Metab. 2012; 10: 444-45.
135. Bornet F, Haardt MJ, Costagliola D, et al. Sucrose or honey at breakfast have no additional acute hyperglycaemic effect over an isoglucidic amount of bread in type 2 diabetic patients. Diabetologia. 1985; 28: 213-7.
136. Katsilambros NL, Philippides P, Touliatou A, et al. Metabolic effects of honey (alone or combined with other foods) in type II diabetics. Acta Diabetol Lat. 1988; 25: 197-203.
137. Chepulis LM. The effect of honey compared to sucrose, mixed sugars, and a sugar-free diet on weight gain in young rats. J Food Sci. 2007; 72: S224-9.
138. Aronoff SL, Berkowitz K, Shreiner B, et al. Glucose metabolism and regulation: beyond insulin and glucagon. Diabetes Spectrum. 2004; 17: 183-90.
139. Al-Waili NS. Natural honey lowers plasma glucose, C-reactive protein, homocysteine, and blood lipids in healthy, diabetic, and hyperlipidemic subjects: comparison with dextrose and sucrose. J Med Food. 2004; 7: 100-7.
140. Busserolles J, Gueux E, Rock E, et al. Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose. J Nutr. 2002; 132: 3379-82.
141. Munstedt K, Hoffmann S, Hauenschild A, et al. Effect of honey on serum cholesterol and lipid values. J Med Food. 2009; 12: 624-8.
142. Erbey JR, Silberman C, Lydick E. Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes. Am J Med. 2000; 109: 588-90.
143. Al-Waili NS. Effects of daily consumption of honey solution on hematological indices and blood levels of minerals and enzymes in normal individuals. J Med Food. 2003; 6: 135-40.
144. Al-Waili NS. Effects of honey on the urinary total nitrite and prostaglandins concentration. Int Urol Nephrol. 2005; 37: 107-11.
145. Ahmed A, Khan RA, Azim MK, et al. Effect of natural honey on human platelets and blood coagulation proteins. Pak J Pharm Sci. 2011; 24: 389-97.
146. Batterham RL, Heffron H, Kapoor S, et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 2006; 4: 223-33.
147. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 2007; 8: 21-34.
148. Larson-Meyer DE, Willis KS, Willis LM, et al. Effect of honey versus sucrose on appetite, appetite-regulating hormones, and postmeal thermogenesis. J Am Coll Nutr. 2010; 29: 482-93.
149. Teff KL, Elliott SS, Tschop M, et al. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab. 2004; 89: 2963-72.
150. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Differential responses to blood pressure and oxidative stress in streptozotocin-induced diabetic wistar-kyoto rats and spontaneously hypertensive rats: effects of antioxidant (honey) treatment. Int J Mol Sci. 2011; 12: 1888-907.
151. Parnell JA, Reimer RA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr. 2009; 89: 1751-9.
152. Gheldof N, Wang XH, Engeseth NJ. Buckwheat honey increases serum antioxidant capacity in humans. J Agric Food Chem. 2003; 51: 1500-5.
153. Erejuwa OO, Sulaiman SA, Wahab MS. Honey: a novel antioxidant. Molecules. 2012; 17: 4400-23.
154. Deibert P, Konig D, Kloock B, et al. Glycaemic and insulinaemic properties of some German honey varieties. Eur J Clin Nutr. 2010; 64: 762-4.
155. Robert SD, Ismail AA. Two varieties of honey that are available in Malaysia gave intermediate glycemic index values when tested among healthy individuals. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009; 153: 145-7.
156. Ischayek JI, Kern M. US honeys varying in glucose and fructose content elicit similar glycemic indexes. J Am Diet Assoc. 2006; 106: 1260-2.
157. Koca I, Koca AF. Poisoning by mad honey: a brief review. Food Chem Toxicol. 2007; 45: 1315-8.
158. Yilmaz O, Eser M, Sahiner A, et al. Hypotension, bradycardia and syncope caused by honey poisoning. Resuscitation. 2006; 68: 405-8.
159. Demir H, Denizbasi A, Onur O. Mad honey intoxication: A case series of 21 patients. ISRN Toxicology. 2011; 2011: 1-3.
160. Aliyev F, Turkoglu C, Celiker C, et al. Chronic mad honey intoxication syndrome: a new form of an old disease? Europace. 2009; 11: 954-6.
161. Fenicia L, Anniballi F. Infant botulism. Ann Ist Super Sanita. 2009; 45: 134-46.
162. Arriagada SD, Wilhelm BJ, Donoso FA. Infant botulism: case report and review. Rev Chilena Infectol. 2009; 26: 162-7.
163. Arnon SS, Midura TF, Damus K, et al. Honey and other environmental risk factors for infant botulism. J Pediatr. 1979; 94: 331-6.
164. Thompson JA, Glasgow LA, Warpinski JR, et al. Infant botulism: clinical spectrum and epidemiology. Pediatrics. 1980; 66: 936-42.
165. Tanzi MG, Gabay MP. Association between honey consumption and infant botulism. Pharmacotherapy. 2002; 22: 1479-83.
166. Fenicia L, Ferrini AM, Aureli P, et al. A case of infant botulism associated with honey feeding in Italy. Eur J Epidemiol. 1993; 9: 671-3.
167. van der Vorsta MMJ, Jamal W, Rotimi VO, et al. Infant botulism due to consumption of contaminated commercially prepared honey. Med Princ Pract 2006; 15: 456-8.
168. Watford M. Small amounts of dietary fructose dramatically increase hepatic glucose uptake through a novel mechanism of glucokinase activation. Nutr Rev. 2002; 60: 253-7.
169. Vozzo R, Baker B, Wittert GA, et al. Glycemic, hormone, and appetite responses to monosaccharide ingestion in patients with type 2 diabetes. Metabolism. 2002; 51: 949-57.
170. Oizumi T, Daimon M, Jimbu Y, et al. A palatinose-based balanced formula improves glucose tolerance, serum free fatty acid levels and body fat composition. Tohoku J Exp Med. 2007; 212: 91-9.
171. Häberer D, Thibault L, Langhans W, et al. Beneficial effects on glucose metabolism of chronic feeding of isomaltulose versus sucrose in rats. Ann Nutr Metab. 2009; 54: 75-82.
172. Sato K, Arai H, Mizuno A, et al. Dietary palatinose and oleic acid ameliorate disorders of glucose and lipid metabolism in Zucker fatty rats. J Nutr. 2007; 137: 1908-15.
173. Cani PD, Knauf C, Iglesias MA, et al. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes. 2006; 55: 1484-90.
174. Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997; 46: 1786-91.
175. Kar A, Choudhary BK, Bandyopadhyay NG. Preliminary studies on the inorganic constituents of some indigenous hypoglycaemic herbs on oral glucose tolerance test. J Ethnopharmacol. 1999; 64: 179-84.
176. Sitasawad S, Deshpande M, Katdare M, et al. Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice (IDDM). Diabetes Res Clin Pract. 2001; 52: 77-84.
177. Song MK, Hwang IK, Rosenthal MJ, et al. Antidiabetic actions of arachidonic acid and zinc in genetically diabetic Goto-Kakizaki rats. Metabolism. 2003; 52: 7-12.
178. Oh HM, Yoon JS. Glycemic control of type 2 diabetic patients after short-term zinc supplementation. Nutr Res Pract. 2008; 2: 283-8.
179. Li F, Zhang G, Liang J, et al. Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto-Kakizaki rats. J Gastrointest Surg. 2009; 13: 2302-8.
180. Folli F, Corradi D, Fanti P, et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro-and macrovascular complications:avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev. 2011; 7: 313-24.
181. Chang YC, Chuang LM. The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. Am J Transl Res. 2010; 2: 316-31.
182. Kim JS, Saengsirisuwan V, Sloniger JA, et al. Oxidant stress and skeletal muscle glucose transport: roles of insulin signaling and p38 MAPK. Free Radic Biol Med. 2006; 41: 818-24.
183. Talior I, Yarkoni M, Bashan N, et al. Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. Am J Physiol Endocrinol Metab. 2003; 285: E295-302.
184. Rudich A, Tirosh A, Potashnik R, et al. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes. 1998; 47: 1562-9.
185. Dokken BB, Saengsirisuwan V, Kim JS, et al. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3. Am J Physiol Endocrinol Metab. 2008; 294: E615-21.
186. Henriksen EJ. Dysregulation of glycogen synthase kinase-3 in skeletal muscle and the etiology of insulin resistance and type 2 diabetes. Curr Diabetes Rev. 2010; 6: 285-93.
187. Tiedge M, Lortz S, Drinkgern J, et al. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 1997; 46: 1733-42.
188. Drews G, Krippeit-Drews P, Dufer M. Oxidative stress and beta-cell dysfunction. Pflugers Arch. 2010; 460: 703-18.
189. Miwa I, Ichimura N, Sugiura M, et al. Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products. Endocrinology. 2000; 141: 2767-72.
190. Tanaka Y, Gleason CE, Tran PO, et al. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A. 1999; 96: 10857-62.
191. Marchetti P, Dotta F, Lauro D, et al. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept. 2008; 146: 4-11.
192. Janjic D, Andereggen E, Deng S, et al. Improved insulin secretion of cryopreserved human islets by antioxidant treatment. Pancreas. 1996; 13: 166-72.
193. Penckofer S, Schwertz D, Florczak K. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J Cardiovasc Nurs. 2002; 16: 68-85.
194. Mohamed M, Sirajudeen K, Swamy M, et al. Studies on the antioxidant properties of Tualang honey of Malaysia. Afr J Tradit Complement Altern Med. 2010; 7: 59-63.
195. Khalil MI, Alam N, Moniruzzaman M, et al. Phenolic acid composition and antioxidant properties of Malaysian honeys. J Food Sci. 2011; 76: C921-8.
196. Kishore RK, Halim AS, Syazana MS, et al. Tualang honey has higher phenolic content and greater radical scavenging activity compared with other honey sources. Nutr Res. 2011; 31: 322-5.
197. Gheldof N, Engeseth NJ. Antioxidant capacity of honeys from various floral sources based on the determination of oxygen radical absorbance capacity and inhibition of in vitro lipoprotein oxidation in human serum samples. J Agric Food Chem. 2002; 50: 3050-5.
198. Fava D, Cassone-Faldetta M, Laurenti O, et al. Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in type 2 diabetes. Diabet Med. 2002; 19: 752-7.
199. Rahimi R, Nikfar S, Larijani B, et al. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005; 59: 365-73.
200. Lai MH. Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and E supplementation for type 2 diabetes mellitus. J Clin Biochem Nutr. 2008; 43: 191-8.
201. Ihara Y, Yamada Y, Toyokuni S, et al. Antioxidant alpha-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett. 2000; 473: 24-6.
202. Opara EC. Role of oxidative stress in the etiology of type 2 diabetes and the effect of antioxidant supplementation on glycemic control. J Investig Med. 2004; 52: 19-23.
203. Erejuwa OO. Management of diabetes mellitus: could simultaneous targeting of hyperglycemia and oxidative stress be a better panacea? IJMS. 2012; 13: 2965-72.
204. Ceriello A, Giugliano D, Quatraro A, et al. Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care. 1991; 14: 68-72.
205. Vinson JA, Howard TB. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem. 1996; 7: 659-63.
206. Lautt WW, Ming Z, Legare DJ. Attenuation of age-and sucrose-induced insulin resistance and syndrome X by a synergistic antioxidant cocktail: the AMIS syndrome and HISS hypothesis. Can J Physiol Pharmacol. 2010; 88: 313-23.
207. Tong X, Dong J, Wu Z, et al. [Whey protein improves insulin resistance via the increase of antioxidant capacity in model rats]. Wei Sheng Yan Jiu. 2011; 40: 617-9.
208. Wright D, Sutherland L. Antioxidant supplemention in the treatment of skeletal muscle insulin resistance: potential mechanisms and clinical relevance. Appl Physiol Nutr Metab. 2008; 33: 21-31.
209. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54: 1615-25.
210. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107: 1058-70.
211. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl. 2000; 77: S26-30.
212. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414: 813-20.
213. Brand MD. The sites and topology of mitochondrial superoxide production. Exp Gerontol. 2010; 45: 466-72.
214. Genuth S, Sun W, Cleary P, et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes. 2005; 54: 3103-11.
215. Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 2003; 52: 818-23.
216. Kowluru RA, Kanwar M, Kennedy A. Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res. 2007; 2007: 1-7.
217. Seghrouchni I, Drai J, Bannier E, et al. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta. 2002; 321: 89-96.
218. Ceriello A. Hypothesis: the "metabolic memory", the new challenge of diabetes. Diabetes Res Clin Pract. 2009; 86 Suppl 1: S2-6.
219. Ihnat MA, Thorpe JE, Kamat CD, et al. Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia. 2007; 50: 1523-31.
220. Ceriello A, Ihnat MA, Thorpe JE. Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab. 2009; 94: 410-5.
221. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Impaired Nrf2-ARE pathway contributes to increased oxidative damage in kidney of spontaneously hypertensive rats: Effect of antioxidant (honey). Int J Cardiol. 2011; 152: S45.
222. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Influence of rat strains and/or severity of hyperglycemia on systolic blood pressure and antioxidant enzymes in kidney of rats with hypertension and/or diabetes: role of honey. Int J Cardiol. 2011; 152: S29.
223. DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993; 329: 977-86.
224. UKPDS. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-53.
225. Cook MN, Girman CJ, Stein PP, et al. Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care. 2005; 28: 995-1000.
226. Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999; 281: 2005-12.
227. Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010; 376: 419-30.
228. Simpson SH, Corabian P, Jacobs P, et al. The cost of major comorbidity in people with diabetes mellitus. CMAJ. 2003; 168: 1661-7.
229. Patel H, Srishanmuganathan J, Car J, et al. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004. J Public Health (Oxf). 2007; 29: 48-52.
230. Justin-Temu M, Nondo RS, Wiedenmayer K, et al. Anti-diabetic drugs in the private and public sector in Dar es Salaam, Tanzania. East Afr Med J. 2009; 86: 110-4.